Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-03-31

Clinical Trial Update: MIRT and Rotigotine in the Early Stage of PD

View source ↗

Summary

Updates on a clinical trial evaluating MIRT and rotigotine for early-stage Parkinson's disease; no results are provided and the trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MIRT
  • Rotigotine (Neupro) (rotigotine)

Snippet

Sponsor: Ospedale Generale Di Zona Moriggia-Pelascini | Conditions: Parkinson's Disease | Status: UNKNOWN